fig3

Cordycepin alleviates oxaliplatin-induced fatty liver disease

Figure 3. Comparison of Histopathological Changes in the Non-Tumor Liver Tissues between the OCG (n = 91) and NCG (n = 70) Groups. (Note: Statistical methods: Chi-squared test. *P < 0.05; **P < 0.01; ***P < 0.001). OCG: Oxaliplatin-based chemotherapy group; NCG: Non-chemotherapy group; G: grade of hepatic inflammation (G0-G4); S: stage of hepatic fibrosis (S0-S4); F: grade of hepatic steatosis (F0-F2); n: number of patients; ns: not significant.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/